NCT05644457 Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck
| NCT ID | NCT05644457 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Royal Marsden NHS Foundation Trust |
| Condition | Head and Neck Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-03-09 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2022-03-09 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
DART is an exploratory molecular analysis study to assess potential early biomarkers of treatment response in squamous cell carcinoma of the head and neck (HNSCC)
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Patients with histologically confirmed cancer of the head and neck with evidence of recurrent or locally advanced cancer not suitable for treatment with curative intent, or metastatic disease. * Receiving immunotherapy * Ability to give informed consent for biological sample collection. Exclusion Criteria: * Unable to undergo serial sample collection * Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05644457 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05644457 currently recruiting?
Yes, NCT05644457 is actively recruiting participants. Contact the research team at ben.oleary@icr.ac.uk for enrollment information.
Where is the NCT05644457 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT05644457 clinical trial?
NCT05644457 is sponsored by Royal Marsden NHS Foundation Trust. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.